Sulthiame: evaluation as an anticonvulsant.
D000927:Anticonvulsants / Q000009:adverse effects; D002986:Clinical Trials as Topic; D004305:Dose-Response Relationship, Drug; D004341:Drug Evaluation; D004569:Electroencephalography; D004827:Epilepsy / Q000097:blood / Q000175:diagnosis; D005886:Gingival Hypertrophy / Q000139:chemically induced; D006801:Humans; D008722:Methods; D009069:Movement Disorders / Q000139:chemically induced; D009759:Nystagmus, Pathologic / Q000139:chemically induced; D010672:Phenytoin / Q000097:blood / Q000627:therapeutic use; D011599:Psychopathology; D012130:Respiratory Hypersensitivity / Q000139:chemically induced; D013843:Thiazines / Q000008:administration & dosage / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use*
D000927:Anticonvulsants; D013843:Thiazines; D010672:Phenytoin